T. Shizawa et al., EFFECTS OF TMK688, A NOVEL ANTIALLERGIC DRUG, ON ALLERGIC NASAL OBSTRUCTION AND EXUDATIVE RESPONSES IN SENSITIZED GUINEA-PIGS, Naunyn-Schmiedeberg's archives of pharmacology, 356(6), 1997, pp. 815-819
TMK688 -[{5'-(3''-methoxy-4''-ethoxycarbonyloxyphenyl)-2' ,4'-pentadie
noyl} aminoethyl]-4-diphenylmethoxypiperidine) is being developed as a
n orally effective antiallergic drug having both 5-lipoxygenase inhibi
tory activity and anti-histamine activity (Shizawa et al. 1996; Tohda
et al. 1997). The efficacy of TMK688 against allergic rhinitis was exa
mined in passively sensitized guinea pigs. TMK688 inhibited the increa
se in intranasal resistance following antigen challenge at doses of 1
and 3.2 mg/kg p.o. The allergic nasal obstruction was also suppressed
by 10 mg/kg i.v. of FPL-55712, a peptide leukotriene receptor antagoni
st, but not by 3.2 mg/kg i.v. pyrilarnine, a histamine H-1 receptor an
tagonist, or by 10 mg/kg p.o. of ketotifen, an anti-allergic drug havi
ng anti-histamine ac tivity, suggesting that the nasal obstruction was
caused by leukotrienes. Following antigen challenge, the intranasal r
elease of leukotrienes B-4 and C-4, and histamine increased in passive
ly sensitized guinea pigs. TMK688 tended to suppress the increase in i
mmunoreactive leukotrienes B-4 and C-4 in the nasal lavage fluid at a
dose of 1 mg/kg p.o., and significantly inhibited the increase at 3.2
mg/kg. The brilliant blue dye leakage following antigen challenge from
the blood stream into the nasal cavities was significantly inhibited
by not only TMK688 and FPL-55712 but also pyrilamine, suggesting that
the allergic dye leakage was caused cooperatively by leukotrienes and
histamine. However, ketotifen showed no significant suppression of the
dye leakage even at 10 mg/kg p.o., although this drug inhibited the h
istamine-induced dye leakage at far lower doses (0.1 mg/kg p.o. or hig
her) in unsensitized guinea pigs. Therefore, histamine is not necessar
ily the major mediator of allergic dye leakage in our experiment. Thes
e findings demonstrate that TMK688 may be superior to antihistamines a
s a therapeutic agent for allergic rhinitis.